NOW AVAILABLE: The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

I am pleased to announce Drug Channels Institute’s new 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers, now available for purchase and immediate download.

• Download a free 32-page report overview–including Key Industry Trends, What’s New in this edition, the Table of Contents, and a List of Exhibits.

• Review pricing and license options and download the full 2026 report.

Special launch pricing discounts will be valid through April 6, 2026.

This report—our seventeenth edition—remains the most comprehensive, fact-based tool for understanding the entire U.S. drug pricing, reimbursement, and dispensing system. If you make strategic decisions in this industry, this report is essential reading.

WHAT’S INSIDE

• Nearly 1,300 endnotes, most of which have hyperlinks to source materials

• Substantial new material—outlined on page x of the report overview

You can pay online with all major credit cards (Visa, MasterCard, American Express, and Discover). Click here to contact us if you would like to pay by corporate check or ACH.

Want to bundle the report with DCI’s video webinars? Email Marie Caldwell (mcaldwell@hmpglobal.com).

If you preordered, you should have received an email with download instructions last week. Didn’t get it? Contact us at dcisupport@hmpglobal.com, and we’ll take care of it.

WHAT’S GOING ON

Every year, the DCI team researches and writes economic reports with up-to-date, fact-based economic analyses of key drug channel participants. Our reports synthesize a wealth of statistical data, research studies, financial information, and our unique business experiences into definitive, nonpartisan resources.

Our goal is simple: help you understand how the drug channel really works—and where it’s going.

That's why DCI reports are widely used by nearly every company involved in the drug channel:

• Pharmaceutical manufacturers

• Wholesalers, pharmacists, and pharmacy owners

• Payers, insurers, and plan sponsors

• Hospitals, benefit managers, and managed care executives

• Policy analysts, investors, consultants, and more

In other words, this report helps you understand what your customers, partners, and competitors are reading—and how they’re thinking.

The chart below illustrates the depth and breadth of the 2026 edition. The numbers indicate the report chapter that corresponds to, explains, and analyzes each channel flow.

FUN FACTS ABOUT THE 2026 EDITION

• The 12 chapters are self-contained—you don't need to read them in order. (Really!) Use the report as a reference guide or read it end-to-end. It’s designed as both a foundational resource and a deep dive into the latest trends and developments.

• There are tons of internal hyperlinks to help you navigate and focus on what matters most to you.

• We’ve updated all market and industry data with the most current insights, including our annual analyses of the largest pharmacies, specialty pharmacies, and PBMs.

• Many sections have been expanded and reorganized to better reflect the latest industry developments. Check out the What’s New section in the report overview for details.

• One of the available licenses gives you the option to download an additional PowerPoint file with images of all 270 exhibits—making it easier to share insights with your team. (Note: All license versions include exhibits within the text.)

• There are a staggering 1,284 endnotes (!), most of which have direct hyperlinks to original source materials. This allows you to validate, explore, and go deeper.

• We have reluctantly removed all corny jokes and pop culture references. So, no memes and absolutely no references to SpongeBob SquarePants.

Thank you for your interest in our work. If you have any questions before purchasing a license to the report, please email me. We look forward to helping you succeed in the evolving U.S. drug channel.